Reuters Health joins The Doctor's Channel

Share this article:
The Doctor's Channel, an online provider of streaming medical videos, has partnered with Reuters Health.
Through the partnership, the companies have launched Reuters Health: The Doctor's Channel Daily Newscast, which offers doctors succinct video content covering Reuters' top three health news stories each day.  

According to David Best, president and founder of The Doctor's Channel, Reuters Health contacted the company with an interest in complementing its health news and informational content with video. For the newscast, The Doctor's Channel converts Reuters' three news selections daily into one- or two- minute videos for doctors.

“The whole concept of The Doctor's Channel is media snacking,” explained Best. Given the preciously few minutes doctors have during the day, short, concise educational videos made sense, he said. “We love YouTube, and we tend to click on videos that are shorter, and avoid the seven- or eight-minute videos,” said Best, who's also an MD. Best adds that an early focus group with doctors viewing online content found a preference for “getting right to the point.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?